Indivior Pharmaceuticals, Inc. (INDV)
40.61
+1.02
(+2.58%)
USD |
NASDAQ |
May 06, 16:00
40.48
-0.13
(-0.32%)
Pre-Market: 08:26
Indivior Pharmaceuticals Cash from Investing (Quarterly) : -19.00M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | -1.403M |
| Catalyst Pharmaceuticals, Inc. | -0.032M |
| Viatris, Inc. | -211.20M |
| Pulse Biosciences, Inc. | -- |
| Revolution Medicines, Inc. | 74.88M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -9.00M |
| Cash from Financing (Quarterly) | 7.00M |
| Free Cash Flow | -193.86M |
| Free Cash Flow Per Share (Quarterly) | -0.2248 |
| Free Cash Flow to Equity (Quarterly) | -187.00M |
| Free Cash Flow to Firm (Quarterly) | -23.58M |
| Free Cash Flow Yield | -3.75% |